Skip to content
Riskpilot
← Back to search
Sign in
Get full access
VIVI IRENE HANSENS FOND TIL FORSKNING AV SYKDOMMEN LUPUS ERYTHEMATOSUS DISSEMINATUS STI
STI
Active
Org 977140242
Activities of other membership organisations n.e.c.
· NACE 9499
Est. 1986 · 40 years old
0 employees
www.unifor.no
Monitor
Share
Norway
/
Companies
/
Activities of other membership organisations n.e.c.
/
VIVI IRENE HANSENS FOND TIL FORSKNING AV SYKDOMMEN LUPUS ERYTHEMATOSUS DISSEMINATUS STI
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
2M
5M
7M
9M
4M
2020
6M
2021
5M
2022
7M
2023
8M
2024
EBITDA
NOK millions
9M
5M
1M
-3M
-6M
4M
2020
5M
+25%
2021
-5M
-200%
2022
7M
+240%
2023
7M
0%
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
4 492
5 515
4 816
6 941
7 543
Staff expenses
−0
−0
−0
−0
−0
EBITDA
4 391
5 419
−4 918
6 838
7 434
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
4 391
5 419
−4 918
6 838
7 434
Net financials
−400
−400
−500
−649
−716
Profit before tax
3 991
5 019
−5 418
6 189
6 718
Tax
−0
−0
−0
−0
−0
Net profit
3 991
5 019
−5 418
6 189
6 718
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
36 459
41 478
36 100
42 248
48 966
Equity
36 459
41 478
36 060
42 248
48 966
Long-term debt
0
0
0
0
0
Short-term debt
0
0
40
0
0
Total debt
0
0
40
0
0
Financial ratios
5-year trend
EBITDA margin
98.6%
This company
15.8%
Market median
+524% vs market
2020
2024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
2020
2024
Return on equity
13.7%
This company
18.4%
Market median
+26% vs market
2020
2024
Net profit margin
89.1%
This company
8.1%
Market median
+1000% vs market
2020
2024
Asset turnover
0.15×
This company
1.12×
Market median
-87% vs market
2020
2024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on VIVI IRENE HANSENS FOND TIL FORSKNING AV SYKDOMMEN LUPUS ERYTHEMATOSUS DISSEMINATUS STI
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
